metylperon has been researched along with Alzheimer Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, AH; Kowar, M | 1 |
| Chowdhury, S; Kumar, S | 1 |
| Delius-Stute, H; Kurz, A; Rettig, K; Schwalen, S | 1 |
4 other study(ies) available for metylperon and Alzheimer Disease
| Article | Year |
|---|---|
[Altered orientation and aggressiveness in an 89-year-old woman].
Topics: Aged, 80 and over; Aggression; Alzheimer Disease; Butyrophenones; Delirium; Diagnosis, Differential; Female; Humans; Orientation; Pacemaker, Artificial; Porphyria, Acute Intermittent; Psychomotor Disorders | 2018 |
In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Antipsychotic Agents; Aspartic Acid Endopeptidases; Butyrophenones; Butyrylcholinesterase; Drug Repositioning; Glucosides; Haloperidol; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Norisoprenoids; Pimozide; Psychotropic Drugs; Receptors, N-Methyl-D-Aspartate | 2017 |
[Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Prospective Studies; Risperidone; Treatment Outcome | 2003 |
[Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Humans; Risperidone; Social Behavior Disorders; Treatment Outcome | 2002 |